Investor Presentaiton

31 ScinoPharm Changeshu - Capturing Chinese Growth on Multiple Fronts Position as a gateway into China providing supply- chain to MNCs Adopt dual-track drug filing process in China and the US Seek generic APIs or intermediates with large demand to increase production utilization Focus on mid- to late-phase CRO projects. Current portfolio includes agents for oncology, anti-hypertension, and diabetes Tighten cost control and process optimization with enhanced management As the back up site for generic API after the Implementation of patent term extension ScinoPharm

View entire presentation